首页> 美国卫生研究院文献>other >Fixed-Dose Combination Drug Approvals Patents and Market Exclusivities Compared to Single Active Ingredient Pharmaceuticals

【2h】

Fixed-Dose Combination Drug Approvals Patents and Market Exclusivities Compared to Single Active Ingredient Pharmaceuticals

机译：与单一有效成分药物相比的固定剂量组合药物许可专利和市场排他性

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

IntroductionFixed-dose combinations (FDC) contain two or more active ingredients. The effective patent and exclusivity life of FDC compared to single active ingredient has not been assessed.

机译：简介固定剂量组合（FDC）包含两种或多种活性成分。与单一活性成分相比，FDC的有效专利寿命和独占寿命尚未评估。

著录项

期刊名称 other
作者
Jing Hao; Rosa Rodriguez-Monguio; Enrique Seoane-Vazquez;
展开▼
作者单位

展开▼
年(卷),期 -1(10),10
年度 -1
页码 e0140708
总页数 13
原文格式 PDF
正文语种
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Fixed-dose combination and single active ingredient drugs: a comparative cost analysis [J] . Hao Jing, Rodriguez-Monguio Rosa, Seoane-Vazquez Enrique Expert review of pharmacoeconomics & outcomes research . 2016 ,第1期

机译：固定剂量联合用药和单一有效成分药物：比较成本分析
2. Comparison of the Analgesic Effects of a Fixed-Dose Combination of Orphenadrine and Diclofenac(Neodolpasse~R)with its Single Active Ingredients Diclofenac and Orphenadrine [J] . Klaus Schaffler, Peter Reitmeir, Andrea Gschanes, Drugs in R&D . 2005 ,第4期

机译：奋乃静和双氯芬酸（Neodolpasse〜R）固定剂量联合使用其单一有效成分双氯芬酸和吗啡的镇痛效果比较
3. Comparison of the Analgesic Effects of a Fixed-Dose Combination of Orphenadrine and Diclofenac(Neodolpasse~R)with its Single Active Ingredients Diclofenac and Orphenadrine [J] . Klaus Schaffler, Peter Reitmeir, Andrea Gschanes, Drugs in R&D . 2005 ,第4期

机译：奋乃静和双氯芬酸（Neodolpasse〜R）固定剂量联合使用其单一有效成分双氯芬酸和吗啡的镇痛效果比较
4. Estimation of Active Pharmaceutical Ingredients Content in Blending Process for Drug Products Manufacturing [C] . Sanghong Kim, Hiroshi Nakagawa, Manabu Kano, AIChE annual meeting . 2010

机译：药品生产混合过程中活性药物成分含量的估算
5. How government policies, patents, and market incentives affect originator and generic pharmaceutical firm behavior towards generic drug entry. [D] . Rhee, Jinnie. 2007

机译：政府政策，专利和市场激励措施如何影响发起人和仿制药公司对仿制药进入的行为。
6. Intellectual property policy in the pharmaceutical sciences: The effect of inappropriate patents and market exclusivity extensions on the health care system [O] . Aaron S. Kesselheim 2007

机译：制药科学领域的知识产权政策：不适当的专利和市场独占性扩展对医疗保健系统的影响
7. Fixed-Dose Combination Drug Approvals, Patents and Market Exclusivities Compared to Single Active Ingredient Pharmaceuticals. [O] . Jing Hao, Rosa Rodriguez-Monguio, Enrique Seoane-Vazquez 2015

机译：固定剂量组合药物批准，专利和市场排他性与单一活性成分药物相比。

Fixed-Dose Combination Drug Approvals Patents and Market Exclusivities Compared to Single Active Ingredient Pharmaceuticals

摘要

著录项

相似文献

相关主题

期刊订阅